Men's health Clinical Trials in Houston, TX

As of September 2026, 58 paid clinical trials are recruiting for Men's health in Houston, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

59 clinical trials for Men's health

·Clear filters·

Email me when a new men's health trial opens in Houston, TX.

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

for Prostate Carcinoma

Drug: Niraparib

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Male·Age: 18+

Code: NCT04947254·Phase 2·Recruiting·Listed Jul 2021

Apply to this trial

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

for Prostate Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Male·Age: 18+

Code: NCT05873192·Phase 2·Recruiting·Listed May 2023

Apply to this trial

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

for Prostate Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Male·Age: 18+

Code: NCT05454488·Phase 2·Recruiting·Listed Jul 2022

Apply to this trial

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

for Prostate Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Male·Age: 65+

Code: NCT05497024·Recruiting·Listed Aug 2022

Apply to this trial

Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS

for Neurogenic Bladder

1 location in Houston

Sponsor: The Methodist Hospital Research Institute

Sex: Female·Age: 18+

Code: NCT06072703·Recruiting·Listed Oct 2023

Apply to this trial

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

for Diabetes

Drug: Tirzepatide

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Male·Age: 18+

Code: NCT06759701·EARLY_Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

for Oncology

Sites in Houston +2 more locations

Sponsor: UMC Utrecht

Sex: All·Age: 18+

Code: NCT04075305·Recruiting·Listed Aug 2019

Apply to this trial

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer

for Prostate Cancer Metastatic

2 locations in Houston

Sponsor: Martha Mims

Sex: Male·Age: 18+

Code: NCT03833921·Phase 2·Recruiting·Listed Feb 2019

Apply to this trial

Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617

for Metastatic Castration-Resistant Prostate Cancer

1 location in Houston

Sponsor: Ebrahim S Delpassand

Sex: Male·Age: 18+

Code: NCT06972628·Phase 2·Recruiting·Listed May 2025

Apply to this trial

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing

for Prostate Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Male·Age: 65+

Code: NCT06785441·Recruiting·Listed Jan 2025

Apply to this trial

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

for Prostate Cancer

Sites in Houston +15 more locations

Sponsor: VA Office of Research and Development

Sex: Male·Age: 18+

Code: NCT04787744·Phase 2, Phase 3·Recruiting·Listed Mar 2021

Apply to this trial

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

for Metastatic Castration-resistant Prostate Cancer

Sites in Houston +24 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT07611110·Phase 3·Recruiting·Listed May 2026

Apply to this trial

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in Houston +10 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 99

Code: NCT07590934·Phase 1, Phase 2·Recruiting·Listed May 2026

Apply to this trial

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in Houston +8 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 130

Code: NCT07181161·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for Endometrial Cancer

Sites in Houston +10 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05489211·Phase 2·Recruiting·Listed Aug 2022

Apply to this trial

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for Prostate Cancer

Drug: Saruparib

Sites in Houston, Spring +35 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT06952803·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Study of AZD0754 in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in Houston, Dallas +11 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 130

Code: NCT06267729·Phase 1, Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

for High-risk Prostate Cancer

1 location in Houston

Sponsor: The Methodist Hospital Research Institute

Sex: Male·Age: 18+

Code: NCT03541928·Phase 2·Recruiting·Listed May 2018

Apply to this trial

Conditions in Men's health (Houston, TX)

Prostate cancer· 49 Metastatic prostate cancer· 18 Overactive bladder· 2